BOSTON -(Dow Jones)- Shares of Boston Scientific Corp. (BSX) dropped Tuesday after the company pointing to challenges facing markets for its top heart devices, implantable defibrillators and drug-coated stents.The Natick, Mass., company issued weaker ...
[Nasdaq - 10/20/2009]